Physician Assistant in New Hudson, MI Accepting Medicare

8 Physician Assistant nurses found. Showing 1 - 8

Lara Barnas, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 30488 Milford Rd, New Hudson, MI 48165 Phone: 248-437-4625

Tamara Ostin, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 30488 Milford Rd, New Hudson, MI 48165 Phone: 248-437-4625

Stephanie Olivia Spitery, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 30488 Milford Rd, New Hudson, MI 48165 Phone: 248-437-4625

Michael Scott Schaeffer Ii, PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 58070 Montego Dr, New Hudson, MI 48165 Phone: 313-670-4527

Bradley Spencer, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 30488 Milford Rd, New Hudson, MI 48165 Phone: 248-437-4625

Kailey Evasic, PA Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 55840 Grand River Ave Ste 300, New Hudson, MI 48165 Phone: 248-264-6169

Katelyn Sheena, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 30488 Milford Rd, New Hudson, MI 48165 Phone: 248-437-4625

Andrew J Jago, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 30488 Milford Rd, New Hudson, MI 48165 Phone: 248-437-4625

News Archive

Oxygen Biotherapeutics first quarter net loss increases to $3.6 million

Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.

First Edition: April 9, 2014

Today's headlines include coverage of the release of Medicare billing and utilization data, as well as early insights into who enrolled in health coverage as a result of the health law.

New nanowire technology may serve as platform to screen drugs for neurological diseases

A team led by engineers at the University of California San Diego has developed nanowires that can record the electrical activity of neurons in fine detail.

Aeterna Zentaris granted FDA orphan-drug designation for AEZS-108 in ovarian cancer

Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received from the U.S. Food and Drug Administration (FDA), orphan-drug designation for AEZS-108, its doxorubicin targeted conjugate compound, for the treatment of ovarian cancer. AEZS-108 is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in Europe.

Single drink of nutritional ketone can alter metabolism to improve performance of cyclists

A drink developed for soldiers to generate energy from ketones rather than carbs or fat allowed highly trained cyclists to add up to 400 meters of distance to their workouts, a UK-led study reports July 27 in Cell Metabolism.

Read more Medical News

› Verified 2 days ago